BackgroundCheck.run
Search For

Richard Eric Chipkin, 735816 Cheshire Dr, Bethesda, MD 20814

Known as:
Richard E Chipkin Richard Katherine Nei Chipkin Richard E Chipman Eric Chipkin

Richard Chipkin Phones & Addresses

5816 Cheshire Dr, Bethesda, MD 20814    301-8978809    301-8978864    301-9192020   

Rehoboth Beach, DE   

Wethersfield, CT   

53 Francisco Ave, Caldwell, NJ 07006    973-2264312   

West Caldwell, NJ   

50 Lindsley Rd, Cedar Grove, NJ 07009    973-7850471   

Bloomfield, NJ   

Get Report
Control this profile

Mentions for Richard Eric Chipkin

Richard Chipkin resumes & CV records

Resumes

Richard Chipkin Photo 9

Richard Chipkin

Location:
Washington D.C. Metro Area
Industry:
Biotechnology

Publications & IP owners

Us Patents

Methods Of Treating Pain And Inflammation With 4,7-Dimethyl-2-(4-Pyridinyl)-1,2,4,-Triazolo[1,5-A]Pyrimidin-5(4H)-One Or The Pharmaceutically Acceptable Salts Or Solvates Thereof

US Patent:
4614743, Sep 30, 1986
Filed:
Dec 27, 1983
Appl. No.:
6/566093
Inventors:
Richard E. Chipkin - Bloomfield NJ
Joseph T. Witkowski - Morris Township, Morris County NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
A61K 31505
C07D48704
US Classification:
514258
Abstract:
The compound 4,7-dimethyl-2-(4-pyridinyl)-1,2,4-triazolo[1,5-a]pyrimidin-5(4H)-one and the pharmaceutically acceptable salts thereof are analgesic and anti-inflammatory agents. Methods for preparing and using the compound and salts are described.

Assay Kit And Methods For Neuroleptic Drugs

US Patent:
5104814, Apr 14, 1992
Filed:
Dec 21, 1990
Appl. No.:
7/631220
Inventors:
Richard Chipkin - West Caldwell NJ
Robert D. McQuade - Scotch Plains NJ
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
G01N 33567
C07D22316
US Classification:
436504
Abstract:
The invention describes a kit and a method useful for analyzing the plasma concentration of an active neuroleptic drug known to have D-1 receptor antagonist properties utilizing labeled [-]trans 6,7,7a,8,9,13b-hexahydro-3-chloro-2-hydroxy-N-methyl-5H-benzo[d]naphtho-[2 ,1-b]-azepine.

Fused Benzazepines For Treatment Of Stuttering

US Patent:
2016027, Sep 22, 2016
Filed:
Oct 17, 2014
Appl. No.:
15/030271
Inventors:
- Germantown MD, US
Richard E. CHIPKIN - Bethesda MD, US
International Classification:
A61K 31/55
A61K 45/06
A61K 9/00
Abstract:
The present invention encompasses methods of treating a subject who stutters. The methods can include the steps of: (a) identifying a subject in need of treatment; and (b) administering to the subject a therapeutically effective amount of a composition comprising a D1/D5 receptor antagonist, a D1/D5 receptor partial agonist, or a mixture thereof. For example, the D1/D5 receptor antagonist can be ecopipam or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, structural analog, metabolite, or polymorph thereof.

Possible Relatives

Richard O Johnson  Richard E Stamps  Richard E Stanbrough  Richard H Stanchfield  Richard W Stanczyk  Richard M Standage  Richard A Standen  Richard F Standifer  Richard C Standley  Richard N Johnston 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.